Image_01
© David Ausserhofer

Technology Transfer

The Technology Transfer Office works with the research community at the MDC to translate their ideas and discoveries into products and services for public benefit. We support applied research, safeguard IP and connect our researchers with external experts and industry to turn research and ideas into technology opportunities and new businesses.

Related news & events

Thomas Blankenstein
© T-knife
Press Release No. 41

Berlin start-up T-knife raises $110 million

T-knife, a spin-off from the MDC and Charité, has raised 110 million U.S. dollars from international investors. The Berlin-based biotech company is developing novel immunotherapies against cancer that focus on teaching a patient’s T cells to recognize and fight solid tumors.
Elisa Kieback
Science

Founder Kieback gets T-knife off to a flying start

A young Berlin-based company called T-knife is a rising star in Germany’s biotech sector. Co-founder Dr. Elisa Kieback, along with colleagues, has catapulted the joint spin-off from the MDC and Charité to the top of the German biotech start-up universe.
neoplastische Plasmazellen exprimieren MAGE-A1

In multiple myeloma, the bone marrow contains many degenerate plasma cells that produce the antigen MAGE-1A (brown). The T cells, genetically engineered with a MAGE-1A-specific receptor, recognize the antigen and target the tumor cells. 

© von Brünneck / Charité
Press Release No. 16

New cancer-fighting immunotherapy enters clinical trials

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells. The safety of the novel therapy is now being tested on patients with bone marrow cancer in a phase I clinical trial.
Teaserbild Ingo Curdt
© Felix Petermann, MDC
Institute & Campus

SPOT: Giving start-ups a head start

With its spin-off support program SPOT, the MDC is giving a helping hand to teams looking to start a company. Three of the most promising projects have now been selected. For our series “We at the MDC” we spoke with Dr. Ingo Curdt, coordinator of the funding program.